Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Parkhill"


8 mentions found


As inflation concerns remain at the forefront of investors' minds, UBS is eyeing stocks that can find growth no matter the economic cycle. "We define compounders as all-weather stocks that leverage operational excellence and competitive advantages to grow through any phase of the economic cycle," analyst Joseph Parkhill wrote on Tuesday. S & P 500 stocks are trading near all-time high valuations of 20 times price to earnings and 14 times enterprise value/EBITDA, Parkhill said. Here's a look at some of the 17 stocks that UBS is watching. Stocks also on the UBS list include artificial intelligence plays Microsoft and Broadcom .
Persons: Joseph Parkhill, Parkhill, AMZN, Stephen Ju, Jay Sole, Stocks Organizations: UBS, Amazon, Microsoft, Broadcom
Small-cap stocks have had a shaky start in 2024, but UBS thinks the sector is worth looking at as a potential broader market rally could boost the sector. Year to date, the Russell 2000 index of small companies is up 2% while the S & P 500 has gained 6.6%. "We view the expectations around interest rates coming down as incrementally a more supportive backdrop for SMID stocks," UBS analyst Joseph Parkhill wrote in a note last week, referring to small- to mid-cap stocks. With these factors in mind, UBS analysts compiled their list of high conviction, small- and mid-cap names which the bank believes have a unique investment thesis behind them. U.S.-traded shares of Zurich-based On have surged more than 22% in 2023, bringing the past 12 months' rally to 45%.
Persons: Russell, Joseph Parkhill, Roger Federer, Jay Sole, Brody Preston, Preston, WAL, Joshua Chan, There's, — CNBC's Michael Bloom Organizations: UBS, Federal, LSEG, Western Alliance Bancorp Locations: ., Zurich, Phoenix, Aramark, Wall
Advertisement"It felt like it was more authentic," Andrea Brimmer, chief marketing and PR officer of Ally Financial, parent of Ally Bank, said of the decision to use the reality format. In another recent example, H&R Block in February dropped "Responsibility Island," a limited series reality spoof based on the popular British reality dating show "Too Hot to Handle." "It is the perfect escape; reality TV is a genre that just delights them." Other brands like Neutrogena have lately co-opted the reality TV format for social media series. Advertisement"To do a purely entertainment reality series is something you don't see every day," said Zoe Fairbourn, head of strategic partnerships and branded entertainment at Hello Sunshine.
Persons: , Emma Grede, Ashley Graham, Ally, Reese Witherspoon's, Andrea Brimmer, Andrew Brimmer, We've, it's, Jill Cress, Cress, Shopify, Zoe Fairbourn, Rick Parkhill, Block, Brimmer, Jill Kargman, Lara Spotts, It'll Organizations: Service, Ally Bank, Business, Ally Bank Brands, Procter, Gamble, Gen, National Geographic, Samsung, YouTube, Galaxy, Disney, Brand, Brands
As studios cut spending and strikes shut down production, Hollywood can take some solace — brands are coming to the rescue. Brand Storytelling is an organization that's held a festival for brand content alongside the Sundance Film Festival for the past seven years. Brand film submissions have almost tripled to 160 in the past three years, according to Rick Parkhill, director and co-founder of Brand Storytelling. "Film directors need the work," said Marcus Peterzell, who left ad giant Omnicom to found Passion Point Collective, a brand film studio, in 2019. He's since made some 36 film projects for brands.
Persons: Greta Gerwig, Kyra Sedgwick, John Deere, Kimberly Doebereiner, Chris Paul, Mattel's Robbie Brenner, There's, Jill Lubochinski, Holly Fraser, WePresent, Ron Howard, Brian Grazer's, Reese Witherspoon's, Michael Sugar's Sugar23, we've, Marc Gilbar, Matt Damon, Ben Affleck, Gilbar, that's, Rick Parkhill, Riz Ahmed, WeTransfer, Vicky Grout, Parkill, Saint Laurent, Pedro Almodóvar, David Cronenberg, They're, Marcus Peterzell, Peterzell Organizations: Hollywood, Mattel, Nike, HBO, Procter & Gamble, Tide, Gillette, G Studios, Warner Bros, Discovery, PepsiCo, REI, Dallas Buyers, Sundance, Brand, Brands Locations: , HBO's, Hollywood
As several macro overhangs weigh on the markets, UBS named its most compelling plays for the rest of 2023. Meta shares have surged more than 117% year to date amid numerous cost-cutting measures, which CEO Mark Zuckerberg termed as the company's " year of efficiency ." Pharmaceutical giant Eli Lilly is another stock UBS thinks can outperform during uncertain times. The bank added that, "Beyond Mounjaro, LLY has a robust pipeline including late-stage Alzheimer's asset donanemab and promising next-generation obesity/T2D assets." UBS thinks the company will continue to benefit from the liquified natural gas backlog, as European countries look for alternatives to Russian gas.
Dividend stocks may be the way to go for investors as a recession becomes more likely, according to UBS. Dividend stocks on average outperformed the market by 4.5% during the 2001, 2008 and 2020 recessions, the bank said. "Dividend stocks can provide a margin of safety during uncertain times." Given this backdrop, UBS highlighted a slew of dividend stocks with big upsides, based on the bank's price targets. Analysts also forecast three-year dividend growth that's at least in the mid-single digits, in addition to sustainable payout ratios.
Feb 21 (Reuters) - Medtronic Plc (MDT.N) said on Tuesday it expects inflation in various markets to hit its profit in the next fiscal year after the medical device maker beat earnings estimate for the third quarter on strong demand for its heart and diabetes devices. While inflation in many countries has eased in recent months, the management expects a delayed improvement in its earnings as its costs remain high. "VBP has affected us more than many of our competitors, given the size and breadth of our business in China. Stifel analyst Rick Wise expects Medtronic to get past pricing pressure in China in "the not too distant future". Reporting by Leroy Leo and Mariam E Sunny in Bengaluru; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.
Nov 22 (Reuters) - Medtronic Plc (MDT.N) on Tuesday lowered its full-year outlook for profit and revenue growth, blaming a stronger dollar and a slower-than-anticipated recovery in supply chain disruptions, sending the medical device maker's shares down nearly 6%. Medtronic cut its revenue growth expectations for fiscal 2023 to 3.5% to 4%, from 4% to 5%. The company said cost-cutting measures will likely offset lower revenue and inflationary pressures in the second half of the year. A slower-than-anticipated recovery in supply chain disruptions impacted Medtronic's medical surgical business the most, with the unit's revenue falling 10% to $2.07 billion. Reporting by Khushi Mandowara and Bhanvi Satija in Bengaluru; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.
Total: 8